Diabetes in ageing: pathways for developing the evidence base for clinical guidance
Year: 2020
Type: article
Institutions: Joslin Diabetes Center, Beth Israel Deaconess Medical Center, Harvard University, University of British Columbia, Hospital Universitario de Getafe, Close Concerns (United States), VA Boston Healthcare System, Tel Aviv University, Sheba Medical Center, King's College London, University of Chicago, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, San Francisco VA Medical Center, University of California, San Francisco, San Francisco VA Health Care System, Massachusetts General Hospital, Nova Southeastern University, Aventura Hospital and Medical Center, AdventHealth Orlando, AdventHealth
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: U.S. Department of Veterans Affairs, Boehringer Ingelheim, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Merck, Sanofi, Leona M. and Harry B. Helmsley Charitable Trust, Takeda Pharmaceuticals U.S.A., Intarcia Therapeutics, Amarin Corporation, Bigfoot Biomedical, Insulet Corporation, MannKind Corporation, Dexcom, Eisai, Novo Nordisk, National Institutes of Health, National Institute on Aging, National Institute of Diabetes and Digestive and Kidney Diseases
OpenAlex ID: W3085703194
